Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8368159rdf:typepubmed:Citationlld:pubmed
pubmed-article:8368159lifeskim:mentionsumls-concept:C0004096lld:lifeskim
pubmed-article:8368159lifeskim:mentionsumls-concept:C0599779lld:lifeskim
pubmed-article:8368159lifeskim:mentionsumls-concept:C0003250lld:lifeskim
pubmed-article:8368159lifeskim:mentionsumls-concept:C0007578lld:lifeskim
pubmed-article:8368159pubmed:dateCreated1993-10-7lld:pubmed
pubmed-article:8368159pubmed:abstractTextCell surface adhesive glycoproteins are principal regulators of nearly all aspects of immune/inflammatory responses. Using monoclonal antibodies to individual adhesion molecules, the expression and contribution of specific molecules in the pathogenesis of allergen-induced airway hyperresponsiveness in monkeys has been deciphered. Results confirm the importance of cell adhesion and demonstrate that antagonism of a single adhesion molecule may provide a novel therapeutic approach.lld:pubmed
pubmed-article:8368159pubmed:languageenglld:pubmed
pubmed-article:8368159pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8368159pubmed:citationSubsetIMlld:pubmed
pubmed-article:8368159pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8368159pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8368159pubmed:statusMEDLINElld:pubmed
pubmed-article:8368159pubmed:issn0379-0363lld:pubmed
pubmed-article:8368159pubmed:authorpubmed-author:LettsL GLGlld:pubmed
pubmed-article:8368159pubmed:authorpubmed-author:WegnerC DCDlld:pubmed
pubmed-article:8368159pubmed:authorpubmed-author:GundelR HRHlld:pubmed
pubmed-article:8368159pubmed:issnTypePrintlld:pubmed
pubmed-article:8368159pubmed:volume43lld:pubmed
pubmed-article:8368159pubmed:ownerNLMlld:pubmed
pubmed-article:8368159pubmed:authorsCompleteYlld:pubmed
pubmed-article:8368159pubmed:pagination151-62lld:pubmed
pubmed-article:8368159pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:8368159pubmed:meshHeadingpubmed-meshheading:8368159-...lld:pubmed
pubmed-article:8368159pubmed:meshHeadingpubmed-meshheading:8368159-...lld:pubmed
pubmed-article:8368159pubmed:meshHeadingpubmed-meshheading:8368159-...lld:pubmed
pubmed-article:8368159pubmed:meshHeadingpubmed-meshheading:8368159-...lld:pubmed
pubmed-article:8368159pubmed:meshHeadingpubmed-meshheading:8368159-...lld:pubmed
pubmed-article:8368159pubmed:meshHeadingpubmed-meshheading:8368159-...lld:pubmed
pubmed-article:8368159pubmed:meshHeadingpubmed-meshheading:8368159-...lld:pubmed
pubmed-article:8368159pubmed:meshHeadingpubmed-meshheading:8368159-...lld:pubmed
pubmed-article:8368159pubmed:meshHeadingpubmed-meshheading:8368159-...lld:pubmed
pubmed-article:8368159pubmed:meshHeadingpubmed-meshheading:8368159-...lld:pubmed
pubmed-article:8368159pubmed:year1993lld:pubmed
pubmed-article:8368159pubmed:articleTitleEfficacy of monoclonal antibodies against adhesion molecules in animal models of asthma.lld:pubmed
pubmed-article:8368159pubmed:affiliationBoehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT 06877.lld:pubmed
pubmed-article:8368159pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8368159pubmed:publicationTypeReviewlld:pubmed